Home

COVID and lung cancer patients

Combined treatment with hydroxychloroquine and azithromycin improves the outcome of Covid-19 in lung cancer patients, detecting only 1/6 deaths between patients under this treatment versus others treatment, with statistical significance in the univariate and multivariate logistic regression (OR 0.04, p = 0.018) COVID-19 in patients with lung cancer COVID-19 is associated with high burden of severity in patients with lung cancer. Patient-specific features, rather than cancer-specific features or treatments, are the greatest determinants of severity. COVID-19 is associated with high burden of severity in patients with lung cancer Lung Cancer Won't Wait: Impact of the COVID-19 Pandemic on Lung Cancer Patients Globally and Lessons Learned The COVID-19 pandemic represents a once-in-a-century global public health challenge, and unfortunately, many aspects of care for cancer patients have been impacted During the COVID-19 pandemic, people's lives have changed dramatically. People with lung cancer who are shielding may have been particularly affected as they may be unable to carry out many of their normal daily activities, such as grocery shopping and exercise, and are unable to interact with friends and family

As of right now there is no definitive data that links novel coronavirus with lung cancer. However, an early study from Wuhan suggested that lung cancer patients had almost twice the risk of.. Severity of COVID-19 is high in lung cancer patients with 62% of patients being hospitalised and 25% who died, but determinants of severity are rather patient-specific, including smoking status and chronic obstructive pulmonary disease (COPD), than tumour-specific characteristics or treatments Doctors have generally recommended that their patients with cancer receive vaccines to protect against infection with SARS-CoV-2, the virus that causes COVID-19. But some people with cancer may not be as protected by the vaccine as people without the disease, results from three new studies suggest MONDAY, June 7, 2021 (HealthDay News) -- Hospitalized patients with active cancer are more likely to die from COVID-19 than those who've survived cancer and patients who've never had cancer, a new.. The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to have a serious impact on many people, including cancer patients, their families, and caregivers. (To learn more about COVID-19 and how it might affect cancer patients and caregivers, see Common Questions About the COVID-19 Outbreak.

For patients who have already had COVID-19: In general, it's recommended that you receive the COVID-19 vaccine even if you were already infected with the virus, although you may choose to wait three to six months after your illness. We all need to remain cautious about COVID-19, especially those with cancer For lung cancer patients, the challenges posed by COVID-19 can include increased risk of complications from COVID-19, as well as changes and delays in treatment and screening schedules The pneumonia that COVID-19 causes tends to take hold in both lungs. Air sacs in the lungs fill with fluid, limiting their ability to take in oxygen and causing shortness of breath, cough and other symptoms. While most people recover from pneumonia without any lasting lung damage, the pneumonia associated with COVID-19 can be severe COVID-19 was severe in patients with lung cancer, but deaths were mainly related to patient-specific features, not cancer-specific features or treatments, according to our retrospective study of 102 patients with lung cancer and COVID-19 diagnoses at Memorial Sloan Kettering Cancer Center (MSK) from March through May 2020 Hospitalized with COVID-19, the patient's cancer symptoms and blood test results suddenly began to improve during the second week of his hospital stay. But the improvement in that case was..

How Does Cancer Flip Off the Body's Immune System? | CTCA

Pecot said as far as he knows, lung cancer by itself does not increase a patient's risk for developing COVID-19. But anything wrong with the lungs, such as asthma or any underlying lung disease and a history of smoking could be problematic. These kinds of things can obviously affect the lungs before getting the virus, he said Dr. David Cooke: Well, as of this writing, we don't have a direct relate link to COVID-19 and lung cancer. But we do have data that suggests that some patients who are being treated for cancer, whether it's lung cancer or other types of cancers, can be at high risk for contracting the virus. And at high risk for dying from the virus once.

Covid-19 and lung cancer: A greater fatality rate

Additionally, the overlap in symptoms between lung cancer and COVID-19—which include persistent cough and breathlessness—has created much opportunity for misdiagnosis during recent months, causing many patients with early-stage lung cancer to self-isolate believing that they have COVID-19, or else be misdiagnosed by their family doctor due to the high prevalence of the virus NCI remains committed to our vital mission of cancer research and is working diligently to meet the needs of cancer patients during the COVID-19 pandemic. That's why today we have launched a long-term, nationwide study, called NCI COVID-19 in Cancer Patients Study (NCCAPS) However, health experts warned that certain factors and comorbidities can put lung cancer patients at a higher risk of developing COVID-19 disease - such as older age, significant cardiovascular disease and respiratory issues, smoking-related damage, and treatment-related immune suppression Lung cancer itself is unlikely to increase the risk of coronavirus complications, however many lung cancer patients are older and frail, having underlying lung disease, and decreased lung capacity. Risk factors for COVID-19 include those with lung cancer, chronic obstructive pulmonary disease (COPD), and those being treated for cancer Caregivers and household members must remember that if they become infected with COVID-19, they risk infecting the cancer patient. Therefore, in order to minimize their risk of becoming infected, they should observe the precautions recommended for the cancer patient as much as possible

COVID-19 & Lung Cancer If I am in active treatment for lung cancer, am I more susceptible to contracting COVID-19? Concerns about becoming sick from infections are higher when a patient is on chemotherapy, particularly as it relates to your body's ability to mount an immune response to fight certain infections and the reserves that your body. Coronavirus is a viral infection that affects the lungs. Anyone who has a weakened immune system is more at risk of being seriously ill if they get coronavirus (COVID-19). Some people with cancer may be at a higher risk of getting coronavirus (COVID-19). It is important to follow the advice from the NHS and your healthcare team The World Economic Forum, in partnership with the Lung Ambition Alliance, launched the COVID-19 Lung Cancer EU Taskforce, to rapidly assess the learnings and address the needs of lung cancer patients whose care was impacted by the COVID-19 pandemic.The Taskforce includes European-level and national policy makers, business leaders, members of patient advocacy groups and professional societies. 20 April - New findings on the effectiveness of the COVID-19 vaccine for cancer patients. A new study, published in The Lancet Haematology has found that the first dose of a COVID-19 vaccine triggers an immune response in around 70% of patients with myeloma. Researchers at The Institute of Cancer Research (ICR) in London and The Royal Marsden.

COVID-19 and Lung Health. You should also ask about the types of patient financial assistance programs that are available to help you cover expenses. Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more COVID-19 symptoms and diagnosis. Lung cancer patients' risk of COVID-19. Mitigating COVID-19 infection risk for early- and late-stage lung cancer patients. Expanding use of telemedicine during the pandemic. Best practices for cancer clinic visits. Decision-making regarding delaying lung cancer therapy. How COVID-19 is impacting molecular testing Please use one of the following formats to cite this article in your essay, paper or report: APA. Thomas, Liji. (2021, February 19). COVID-19 and lung cancer have a common pathway, say researchers Treatment for lung cancer should start when the patient has recovered completely without any complication, inflammatory markers have normalized, repeat throat swab test for Covid is negative and.

People with cancer, people who are in active cancer treatment, older patients, and people with other serious chronic medical conditions, such as lung disease, diabetes, or heart disease, are at higher risk for the more severe form of COVID-19 that could lead to death We read the excellent Comment by Wenhua Liang and colleagues1 in The Lancet Oncology with great interest. Of 1590 cases with confirmed coronavirus disease 2019 (COVID-19), 18 patients had a history of cancer. The authors concluded that patients with cancer had a higher risk of COVID-19 and with a poorer prognosis than those without cancer Other health conditions, such as heart or lung disease, can increase your risk of developing dangerous symptoms if you become infected with coronavirus disease 2019 (COVID-19). By Mayo Clinic Staff Coronavirus disease 2019 (COVID-19) symptoms can vary widely Dr Sarah Challoner, one of the doctors treating the cancer at the Royal Cornwall Hospital in Truro, said in the published report: 'We think Covid-19 triggered an anti-tumour immune response.

A total of 162 patients with newly diagnosed lung cancer were enrolled in the study, including 100 who were diagnosed pre-COVID-19 and 62 during COVID-19. A decrease of 38% in diagnoses was observed between the 2 periods. Of these patients, 68% had NSCLC and 32% had SCLC. The median age was around 66 years old and the majority were male (70%. Depending on your experience with COVID-19, the following complications may have occurred and may require additional support and recovery. Pneumonia, a lung infection that can be life threatening. Lung abscesses, which are infrequent, but serious complications of pneumonia. They occur when pockets of pus form inside or around the lung Also, many lung cancer patients may have developed the disease after smoking tobacco, potentially adding additional layers of existing conditions, such as COPD, that may make them more vulnerable to severe COVID-19 symptoms. Some patients with lung cancer have diminished lung function, and many have a history of smoking, so they are more.

Mortality appeared unexpectedly high among individuals with lung cancer and COVID-19 infection, according to international registry data presented at the virtual American Association for Cancer. One third of patients hospitalized with COVID-19 have lung changes after a year. A new study has shown that most patients discharged from hospital after experiencing severe COVID-19 infection. Background: Cancer patients represent a vulnerable population for COVID-19 illness. We aimed to analyze outcomes of lung cancer patients affected by COVID-19 in a tertiary hospital of a high-incidence region during the pandemic.Methods: We annotated 23 lung cancer patients consecutively diagnosed with COVID-19 at our institution (HGUGM; Madrid, Spain) between March 4th, 2020 and May 12th, 2020

COVID-19 in patients with lung cancer - PubMe

The American Cancer Society Cancer Action Network (ACS CAN) is making the impact of COVID-19 in cancer patients a top priority for public officials. The ongoing impact of COVID-19 on the cancer community. Cancer patients increasingly face COVID-19 health impact. How COVID-19 is affecting patients' access to cancer care While all cancer patients may need to discuss their specific risks associated with COVID-19, special consideration must be given to people with lung cancer, due to the respiratory nature of COVID-19, and blood cancers, which can affect the immune system's ability to root out infections caused by this new coronavirus They include elderly patients who've had severe bouts of COVID-19 pneumonia, patients with other illnesses such as cancer or diabetes and those with other lung conditions caused by smoking or. As we look to restore cancer care to pre-COVID-19, this change in behavior is cause for concern, especially for those at risk of or potentially living with undiagnosed lung cancer The ongoing COVID-19 pandemic may bring up fears and questions for people who have been through cancer treatment.. As Director of Memorial Sloan Kettering's Adult Long-Term Follow-Up Program, Emily Tonorezos oversees the care of adults who had a pediatric cancer. We spoke with her about what cancer survivors should know about COVID-19 and how they can stay safe through these uncertain times

Lung Cancer Won't Wait: Impact of the COVID-19 Pandemic on

The authors also suggest COVID-19 vaccination could alleviate some of the fear and stress cancer patients and their caregivers experience owing to the fear of death and stigma associated with cancer treatment, and enable cancer patients to feel safe while seeking care in medical centers or enrolling in clinical trials Luo et al, Ann Oncol and Calles et al, Front Oncol have reported high rates of mortality among patients with lung cancer and confirmed COVID-19, and a systematic review by Peravali et al, JTO Clin Res Rep reported an OR of 1.62 (95% CI 1.06-2.48) for increased mortality between patients with lung cancer and those with other cancers The COVID-19 pandemic has had an impact on clinical trials for lung cancer, with only 14% of sites in Europe continuing to enrol patients at the same level as prior to the pandemic. On the other hand, we have also seen innovations in the way trials are conducted and reviewed, such as greater use of real-world evidence, remote monitoring and. COVID-19 vaccines are currently in short supply, but UPMC cancer experts say it is critical for cancer patients to get immunized when doses become available. Dr. Stanley Marks According to a recent paper published in the Journal of the American Medical Association , cancer — particularly leukemia, lymphoma and lung cancer — is associated. Covid kills a FIFTH of all cancer patients - with lung and blood cancer sufferers the most at risk. Research looked at 15 studies from across the globe involving 3,019 patients. Analysis of the.

Impact of COVID-19 on Lung Cancer Patients - Full Text

Patients with cancer are at increased risk of severe illness from COVID-19 [15, 48,49,50,51].In a study of 73 million patients in the USA, of whom 273,000 had been diagnosed with cancer in the last year and 16,570 were diagnosed with COVID-19, patients with cancer had greatly increased odds of COVID-19 infection (adjusted odds ratio (aOR) of 7; []) The surgical team at MedUni Vienna and Vienna General Hospital has meanwhile carried out twelve lung transplantations on COVID-19 patients, demonstrating that even the most seriously ill patients. Many people suffering from long Covid have a worse quality of life than patients with advanced lung cancer, according to the first major study to quantify the impact of the condition on people's. More than 47% of cancer patients with COVID-19 were hospitalized versus 24% of COVID-19 patients without cancer. The study also showed about 15% of patients with cancer died from COVID-19 compared. The COVID-Lung Cancer Consortium, which represents a global assembly of leaders in thoracic oncology, virology and immunology, wrote a statement urging officials to prioritize all patients with cancer. Are COVID-19 Vaccines Safe for Cancer Patients? Patients undergoing active cancer treatment, such as chemotherapy for mesothelioma, should.

Lung Cancer and Coronavirus - Symptoms, Risk, Treatment

COVID-19 vaccines and cancer patients: Answers to 9 common questions. As cancer patients wait to be among those approved to begin getting the vaccine, many have questions specific to how safe and effective the COVID-19 vaccines will be for them. The much-anticipated rollouts of the first COVID-19 vaccines were greeted with applause and fanfare Lung cancer patients are at high risk of coronavirus complications, according to a JAMA Oncology study published March 25, 2020. Among 228 patients with non-small cell lung cancer at a facility in Wuhan, China, seven patients were diagnosed with COVID-19 pneumonia

Severity of COVID-19 in Lung Cancer Patient

  1. The COVID-19 vaccines have not been studied specifically in patients with cancer. As such, how your immune system responds may be influenced by your general health and your cancer treatment. Some types of cancer and their treatment can increase the risk of catching COVID-19 and of poorer impacts to treatment and recovery
  2. Cancer patient prioritisation. The tiered approach of ESMO in delivering a guidance for cancer patients during the COVID-19 pandemic is designed across three levels of priorities, namely: tier 1 (high priority intervention), 2 (medium priority) and 3 (low priority) - defined according to the criteria of the Cancer Care Ontario, Huntsman.
  3. The Lancet study looked at 928 cancer patients who caught COVID-19 from mid-March to mid-April in the United States, Canada and Spain. Advanced age had a significant effect on risk, Choueiri said.
  4. Because COVID-19 is primarily a respiratory condition, this disease presents a unique challenge to lung cancer patients, who are at extremely high risk of hospitalization and death from COVID-19.
  5. As COVID-19 is a disease of the respiratory tract, previous studies have concluded that patients with lung cancer often experience severe manifestations when infected by SARS-CoV-2 and are at a higher mortality risk than patients with other cancer types (Antonio et al., 2020). An investigation that took place in China suggested that 18 out of.
  6. AACR 2020 — Registry data suggest an unexpectedly high mortality rate among patients with lung cancer who develop COVID-19, according to a presenter at the AACR virtual meeting I. Data from.
  7. Long Covid feels worse than advanced lung cancer for many patients, study finds Exclusive A study of 800 long Covid suffers at 15 NHS Hospital trusts found the condition is severely impacting on.

Because patients with lung cancer experience more severe COVID-19 symptoms and higher associated mortality, there have been widespread efforts by clinicians to minimize SARS-CoV-2 exposure The goal of this activity is to improve clinicians' understanding of the effect of COVID-19 on patients with lung cancer and how best to manage these patients. Upon completion of this activity, participants will: Have increased knowledge regarding the Effect of COVID-19 on patients with lung cancer receiving systemic therapy. COVID-19 and cancer biology. In patients with cancer, COVID-19 can be especially harsh. This is likely because many patients have a weakened immune system — either as a result of the cancer itself or the therapies used to treat it — and are therefore less able to fight off infection by the novel coronavirus. Several studies have examined. There have been a couple of studies about breakthrough COVID-19 cases among vaccinated transplant recipients. Columbia University studied 904 kidney and pancreas transplant patients who got the vaccine. Thirteen of them contracted COVID-19, and seven of those cases met the CDC definition of a breakthrough infection

In People with Cancer, Responses to COVID-19 Vaccines Vary

Study Pinpoints Cancer Patients at Highest Risk From COVI

  1. Australia has embarked on a national COVID-19 vaccine roll-out. Cancer Australia is working with the cancer community and the Australian Government Department of Health to develop timely information about COVID-19 vaccines for people affected by cancer
  2. Sherry Haines, lung cancer patient and COVID-19 survivor. Haines went to the emergency room, where she told medical staff that she has lung cancer, along with the suspicion that she might have.
  3. Data have shown that somewhere between 13% and 15% of patients who develop cancer can die of COVID-19.. Yet, Pergam said he imagines it must be really hard for the average patient with.
  4. Patients with lung cancer, given their commitment to underlying lung function, represent a particularly vulnerable group to COVID-19. Furthermore, the most common symptoms of COVID-19 and lung cancer, such as cough and dyspnoea, can overlap, thus delaying diagnosis

The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection. For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used The care of a patient with lung cancer and may involve a multitude of different types treatment including chemotherapy, radiotherapy or immunotherapy and surgery. Take precaution to avoid COVID-19 risks. For patients who are currently undergoing treatment for lung cancer, Dr. Blackmon recommends taking strict quarantine measures COVID-19 and Long-Term Lung Damage. While there is a roughly 97% recovery rate among the 16 million Americans who have been diagnosed with COVID-19 since March, that doesn't mean all of them have returned to good health. According to the Centers for Disease Control and Prevention (CDC), people with certain medical conditions such as cancer. Fever, cough and shortness of breath are common symptoms of COVID-19 infection and would be expected to be common in cancer patients with the infection as well People who are being treated for cancer may be at increased risk of severe COVID-19, and clinical outcomes of COVID-19 are generally worse in people with cancer than in people without cancer. 1-4 A meta-analysis of 46,499 patients with COVID-19 showed that all-cause mortality (risk ratio 1.66; 95% CI, 1.33-2.07) was higher in patients with cancer, and that patients with cancer were more.

For most cancers, a lot of transplant centers would like to wait at least two years after cure of cancer, but we take unusual candidates for transplant. We did that because surgery was successful and his PSA level was undetectable. Many patients with COVID-19 infection recover back to their normal lung function Yes, the COVID-19 vaccines are safe and recommended for cancer patients. Most people with cancer or a history of cancer are advised to get the COVID-19 vaccine. Some cancer treatments like chemotherapy, radiation, stem cell transplant, or immunotherapy can affect the immune system, which might make the vaccine less effective. People with. Medical centers have been flooded with calls from anxious patients with lung cancer who want to know how COVID-19, a coronavirus that has grown into a pandemic, will impact them and their. Lung Cancer Symptoms & COVID-19. Lung cancer and COVID-19 share a distinctive symptom, says Cancer Research UK. They warn that having a new, continuous cough is something to tell your doctor about. That is especially true if it also comes with loss of appetite, unplanned weight loss, or fatigue, as these can be telling signs of cancer A study analyzed 1590 patients with COVID-19 as of January 31, 2020, 18 (1%) had a history of cancer, 28% of cancer patient were lung cancer patients. Cancer patients have a higher risk of serious events than non-cancer patients (39 and 8%, P = 0.000,3), and symptoms deteriorate more rapidly

Patients with lung cancer are probably not at a greater risk for contracting COVID-19, but likely have a substantially increased risk for death from the virus as many patients with lung cancer. A retrospective study of 57 adult COVID-19 patients published yesterday in Respiratory Research found significant lung impairment in the recovery phase, particularly in patients with severe disease.. Researchers conducted serial assessments of patients 30 days after they were released from the Fifth Affiliated Hospital of Sun Yat-sen University in Zhuhai, China

COVID-19 Vaccines in People with Cance

LUNG cancer is the forgotten disease of the Covid pandemic with 14,000 fewer patients referred for urgent checks, a report claims. Cancer Research UK said lung cancer has been hit harder. Whether a hospital should halt lung cancer screening during COVID-19 or any other pandemic depends on factors such as local infections and resource availability, debaters agreed at the Society of. The number of early lung cancers has decreased - we are seeing quite a bit more late-stage cancer - so we have to assume that the delay in diagnosis due to Covid has played a part in that. Second, patients with cancer, especially those with hematological malignancies, lung cancer, and active malignancies, are at risk of a fatal outcome of COVID-19 1,2 Coronavirus: Lung cancers 'may have been misdiagnosed as COVID' during pandemic . Some patients who had a cough and could have lung cancer were told to stay home for fear they had caught coronavirus

Can I Get the COVID-19 Vaccine If I Have Cancer

  1. Scientists looked at data from across the globe and found that cancer patients who contracted COVID-19 face a mortality rate of 22.4%. This is 273 time higher than the mortality rate for COVID-19.
  2. Furthermore, cancer patients, elderly and those with comorbidities are at high risk of developing COVID-19 related morbidity and mortality (1, 2). This is especially true for lung cancer patients, with reported mortality rates of 25%-55% (3-6), compared with up to 10 % in other COVID-19 patients (5)
  3. The fear of contracting COVID-19 among patients with lung cancer is palpable, and three new research studies presented today underscore how vulnerable patients with lung cancer feel as they cope.

Ensuring Lung Cancer Patient Safety During the COVID-19

Despite optimal medical therapy, some patients with severe COVID-19 develop irreversible lung injury. In these patients who cannot be weaned from mechanical ventilation or extracorporeal life support, lung transplantation may be the only life-saving option. Bharat et al . now report the results of lung transplantation in three patients who had COVID-19-associated respiratory failure A main feature of COVID-19 is lung inflammation and respiratory failure caused by an overexuberant immune response known as the cytokine storm. In patients with severe COVID this pathway.

Concerned about coronavirus? Here are the steps cancer

COVID-19 Lung Damage Johns Hopkins Medicin

The National Cancer Institute is reporting a decrease in the number of lung cancer cases. COVID 19 and Lung Cancer. Posted because we know we are missing a lot of lung cancer patients.. A: Cancer patients who get COVID-19 are at higher risk for complications, hospitalizations and even death compared to healthy people who get COVID-19. That's because cancer patients in active treatment can have a weakened immune system, which makes it harder to fight off diseases such as COVID-19 the other hand, it is known that 20-40% of the patients develop unilateral CT scan COVID-19 lung damage, while both lungs could be concerned in the other patients (5). In breast cancer RT, the lung volume is greater when regional nodal irradiation (RNI) is indicated. In the present case, as shown in Figure 3B, COVID-19 induced lung damage i Lung cancer can be challenging to diagnose even under normal circumstances; therefore, it is more important than ever to be alert to the risk of suspected lung cancer in your patients, with the added possibility of symptoms now being disguised by potential COVID-19 symptoms In addition to encouraging these interactions, which may help alleviate loneliness, NPs also can make patients aware of remote support groups for both lung cancer and COVID-19. Tend to provider.

Severity of COVID-19 in Patients with Lung Cancer: Not

  1. As COVID vaccines are being rolled out, an extremely vulnerable group is being overlooked: millions of cancer patients.Doctors are sounding the alarm that many state governments and the federal.
  2. COVID-19's effect on cancer patients is a key concern to the cancer community with delayed or decreased diagnosis, tests and treatment. To understand this variable and rapidly changing landscape the Cancer Intelligence team are regularly monitoring published data around the impact of the pandemic across the cancer pathway
  3. Winship Cancer Institute of Emory University (Winship) and Emory investigators are testing whether an anticancer drug can reduce lung inflammation in hospitalized COVID-19 patients, possibly preventing the need for intubation and lowering mortality. The drug is called duvelisib, and it was FDA-approved in 2018 for the treatment of relapsed or.
  4. Lung transplantation can potentially be a life-saving treatment for patients with nonresolving COVID-19-associated respiratory failure. Concerns limiting lung transplantation include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and the potential risk for allograft infection by pathogens causing ventilator.
  5. PATNA: Doctors of at least three dedicated Covid hospitals in the city have detected a worrying trend of cured Covid-19 patients returning a few weeks later with lung fibrosis — scarring of.
Testing Combination Immunotherapy in Advanced Lung CancerBusting myths: 7 common chemotherapy misconceptions | CTCALondon Landmarks Half Marathon - Roy Castle Lung CancerStroke Drug Could Help COVID-19 PatientsThe Difference: Male And Female Breast Cancer | CTCAWhat Is Chemotherapy? The Ins And Outs Of Treatment, AndBreast cancer - causes, symptoms, diagnosis, treatment

Older cancer patients may be the most vulnerable to severe COVID-19 complications, especially when their immune systems are compromised from cancer, cancer treatment, other underlying conditions. The reasons why both the elderly and cancer patients are at high risk for COVID-19 infections may be similar: older age, immunosuppression, and concurrent health problems Yet cancer patients are getting decimated by COVID-19. New data from 360 U.S. hospitals show that patients with cancer are more at risk of catching COVID-19 than the rest of the population. Once. Yet cancer patients are getting decimated by COVID-19. New data from 360 U.S. hospitals show that patients with cancer are more at risk of catching COVID-19 than the rest of the population Consensus statements were developed to guide clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. Materials and Methods An expert panel of 24 members, including pulmonologists (n = 17), thoracic radiologists (n = 5), and thoracic surgeons (n = 2), was formed